Track topics on Twitter Track topics that are important to you
Angiogenix is a biopharmaceutical company developing therapeutic solutions for chronic vascular disease. We are a product-oriented company. Our products generally address the improvement of blood flow by improving vascular function. Within this framework, our products cover a broad range of types and indications, from novel combination drugs to a new proprietary drug for sickle cell disease. We also seek early stage opportunities for development by our experienced clinical development team.
500 Airport Blvd., #100
United States of America
Angiogenix is a biopharmaceutical company developing therapeutic solutions for chronic vascular disease. We are a product-oriented company. Our products generally address the improvement of blood flow...
We have published hundreds of Angiogenix, Inc. news stories on BioPortfolio along with dozens of Angiogenix, Inc. Clinical Trials and PubMed Articles about Angiogenix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Angiogenix, Inc. Companies in our database. You can also find out about relevant Angiogenix, Inc. Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...